Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.

A control series of 105 patients in hospital with non-malignant diseases was used in a limited clinical assessment of the MOD-MEM test. Twenty-seven positive results could be explained on the basis of destruction of nervous parenchyma, tissue necrosis, tuberculosis, malignant disease, etc. The remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchard, J. A., Moore, J. L., Sutherland, W. H., Joslin, C. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1976
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025130/
https://www.ncbi.nlm.nih.gov/pubmed/60118
_version_ 1782136702499815424
author Pritchard, J. A.
Moore, J. L.
Sutherland, W. H.
Joslin, C. A.
author_facet Pritchard, J. A.
Moore, J. L.
Sutherland, W. H.
Joslin, C. A.
author_sort Pritchard, J. A.
collection PubMed
description A control series of 105 patients in hospital with non-malignant diseases was used in a limited clinical assessment of the MOD-MEM test. Twenty-seven positive results could be explained on the basis of destruction of nervous parenchyma, tissue necrosis, tuberculosis, malignant disease, etc. The remaining 13 unexplained positives showed a sex and age distribution in agreement with that predicted from cancer registration statistics if the MOD-MEM test detects cancer about 16 years before the clinical appearance of the disease.
format Text
id pubmed-2025130
institution National Center for Biotechnology Information
language English
publishDate 1976
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20251302009-09-10 Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases. Pritchard, J. A. Moore, J. L. Sutherland, W. H. Joslin, C. A. Br J Cancer Research Article A control series of 105 patients in hospital with non-malignant diseases was used in a limited clinical assessment of the MOD-MEM test. Twenty-seven positive results could be explained on the basis of destruction of nervous parenchyma, tissue necrosis, tuberculosis, malignant disease, etc. The remaining 13 unexplained positives showed a sex and age distribution in agreement with that predicted from cancer registration statistics if the MOD-MEM test detects cancer about 16 years before the clinical appearance of the disease. Nature Publishing Group 1976-07 /pmc/articles/PMC2025130/ /pubmed/60118 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Pritchard, J. A.
Moore, J. L.
Sutherland, W. H.
Joslin, C. A.
Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title_full Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title_fullStr Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title_full_unstemmed Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title_short Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
title_sort clinical assessment of the mod-mem cancer test in controls with non-malignant diseases.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025130/
https://www.ncbi.nlm.nih.gov/pubmed/60118
work_keys_str_mv AT pritchardja clinicalassessmentofthemodmemcancertestincontrolswithnonmalignantdiseases
AT moorejl clinicalassessmentofthemodmemcancertestincontrolswithnonmalignantdiseases
AT sutherlandwh clinicalassessmentofthemodmemcancertestincontrolswithnonmalignantdiseases
AT joslinca clinicalassessmentofthemodmemcancertestincontrolswithnonmalignantdiseases

Ejemplares similares